Back Home Search

Kidney

    • Protocols

    • A032201

      OPEN TO ACCRUAL

      Ph 3 Pembrolizumab vs Pembro + Tivozanib for High-Risk RCC

    • NRGGU012

      OPEN TO ACCRUAL

      P2: SABR for Metastatic Unresected RCC with Immunotherapy (SAMURAI)